A randomized controlled trial on the influence of structured advance care planning on quality of end-of-life care communication and quality of end-of-life care in patients with COPD.

A randomized controlled trial on the influence of structured advance care planning on quality of end-of-life care communication and quality of end-of-life care in patients with COPD. - Advance care planning in COPD.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON40110

Enrollment

900

Registered

2013-01-22

Start date

2013-06-21

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease COPD

Interventions

Respiratory nurse specialists will provide the structured advance care planning session in the patients home environment in the presence of the patient and his or her loved ones. Respiratory nurse s

understanding the current and future medical situation, possible treatments and outcomes

understanding life-sustaining treatments

determining wishes regarding current and future care

encouraging discussion of advance care planning with health care providers and loved ones

and appointment of a surrogate decision maker. The advance care planning session will be adapted to the patients needs. The duration will be about 1.5 hours. Respiratory nurse specialists will be s

preferences for life-sustaining treatments

and questions and concerns regarding end-of-life care. This feedback form will be provided to the patient, the chest physician and general practitioner. Finally, patients will receive a brochure abo

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients: - A diagnosis of severe to very severe COPD (GOLD grade III or IV or quadrant D) according to GOLD guidelines. - Initiation of oxygen therapy or discharged after hospital admission for an acute COPD exacerbation. -At least one loved one, who will participate in the study.

Exclusion criteria

Exclusion criteria: - Unable to complete the study questionnaires because of cognitive impairment. - Unable to speak or understand Dutch.

Design outcomes

Primary

Measure	Time frame
The main study parameters will be: - Quality of communication about end-of-life care - Symptoms of anxiety and depression - Quality of end-of-life care - Quality of dying	—

Secondary

Measure	Time frame
The secondary parameters will be: - Patient*s preferences for end-of-life care - Received end-of-life care - Psychological distress in bereaved family members of deceased patients with COPD	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)